Department of Marine Biomedicine and Polar Medicine, Naval Medical Center, Naval Medical University, Shanghai 200433, China.
Department of Neurosurgery, 922th Hospital of PLA, Hengyang 421000, China.
Nutrients. 2023 Jan 24;15(3):607. doi: 10.3390/nu15030607.
Gut microbiota is the largest and most complex microflora in the human body, which plays a crucial role in human health and disease. Over the past 20 years, the bidirectional communication between gut microbiota and extra-intestinal organs has been extensively studied. A better comprehension of the alternative mechanisms for physiological and pathophysiological processes could pave the way for health. Cardiovascular disease (CVD) is one of the most common diseases that seriously threatens human health. Although previous studies have shown that cardiovascular diseases, such as heart failure, hypertension, and coronary atherosclerosis, are closely related to gut microbiota, limited understanding of the complex pathogenesis leads to poor effectiveness of clinical treatment. Dysregulation of inflammation always accounts for the damaged gastrointestinal function and deranged interaction with the cardiovascular system. This review focuses on the characteristics of gut microbiota in CVD and the significance of inflammation regulation during the whole process. In addition, strategies to prevent and treat CVD through proper regulation of gut microbiota and its metabolites are also discussed.
肠道微生物群是人体内最大、最复杂的微生物群,在人类健康和疾病中起着至关重要的作用。在过去的 20 年中,肠道微生物群与肠外器官之间的双向通信得到了广泛研究。更好地理解生理和病理生理过程的替代机制可能为健康铺平道路。心血管疾病(CVD)是最常见的疾病之一,严重威胁着人类健康。尽管先前的研究表明,心血管疾病,如心力衰竭、高血压和冠状动脉粥样硬化,与肠道微生物群密切相关,但对复杂发病机制的有限理解导致临床治疗效果不佳。炎症失调总是导致胃肠道功能受损和与心血管系统的交互紊乱。本综述重点介绍了 CVD 中肠道微生物群的特征以及炎症调节在整个过程中的意义。此外,还讨论了通过适当调节肠道微生物群及其代谢物来预防和治疗 CVD 的策略。